Publication | Closed Access
USP18 protects against hepatic steatosis and insulin resistance through its deubiquitinating activity
98
Citations
31
References
2017
Year
USP18 associates with and deubiquitinates TAK1 to protect against hepatic steatosis, insulin resistance, and the inflammatory response. (Hepatology 2017;66:1866-1884).
| Year | Citations | |
|---|---|---|
Page 1
Page 1